Retroperitoneal lymph node dissection for residual masses after chemotherapyin nonseminomatous germ cell testicular tumor
<p>Abstract</p> <p>Background</p> <p>Retroperitoneal lymph node dissection has been advocated for the management of post-chemotherapy (PC-RPLND) residual masses of non-seminomatous germ cell tumors of the testis (NSGCT). There remains some debate as to the clinical bene...
Main Authors: | Tanguay Simon, Brimo Fadi, Aldousari Saad, Kotb Ahmed F, Luz Murilo A, Kassouf Wassim, Aprikian Armen G |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | World Journal of Surgical Oncology |
Online Access: | http://www.wjso.com/content/8/1/97 |
Similar Items
-
Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors
by: Thomas J. Guzzo, et al.
Published: (2009-06-01) -
Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study
by: K.-P. Dieckmann, et al.
Published: (2018-10-01) -
A retrospective analysis of patients undergoing postchemotherapy retroperitoneal lymph node dissection and metastasectomy in advanced nonseminomatous germ cell tumors
by: Kanuj Malik, et al.
Published: (2020-01-01) -
Laparoscopic Retroperitoneal Lymph Node Dissection for Stage I Nonseminomatous Germ Cell Testis Tumors: The First Case Series in Iran
by: Seyed Amir Mohsen Ziaee, et al.
Published: (2011-03-01) -
Anatomical retroperitoneoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors: initial operative experience
by: Kai Yao, et al.
Published: (2014-02-01)